Commercial opportunity and PMA potential for radiotherapy device supporting novel procedure in cardiology

September 1, 2020

Our client was preparing to launch an upgrade to their radiotherapy devices and wanted to understand the commercial potential, preferred business models and likely funding pathways.

CRA approach

  • Country wise landscape assessment and identification of treatment pathway, positioning, competition, stakeholders and workflow changes, HTA process, funding pathways, and value drivers
  • Developed framework to define potential business models to sell upgrade only or whole device to hospitals
  • Developed hypothesis on potential funding pathways and promising business models, and identified gaps to close in primary market research

Client impact

  • Clear overview of most likely product positioning, stakeholder types and required workflow changes, and drivers/barriers for adoption country by country
  • Hypothesis on optimal route to market, business models to sell technology to hospitals as well as potential price points for new procedure reimbursement
  • Identification of knowledge gaps and clear recommendation on stakeholders and questions guiding primary market research to close gaps
Countries Involved
  • United States
  • France
  • Italy
  • Germany
  • Spain
  • United Kingdom
  • Japan
Related capabilities